Dartmouth College
Dartmouth Spinoff Episteme Prognostics Aims to Bring Precision Epigenetics to Pancreatic Cancer
Premium
The researchers at the startup have developed a microarray test to predict patients' response to chemotherapy based on chromatin accessibility.
Researchers separately found that the assay had high concordance with other techniques in cancers including colorectal and endometrial carcinomas.